Eli Lilly Breaks Ground On Fifth U.S. API Manufacturing Site In Houston

Eli Lilly and Company broke ground on its fifth U.S. active pharmaceutical ingredient (API) manufacturing site in Houston. The facility will produce APIs for medicines such as Foundayo.